Morling Financial Advisors’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$285K Buy
716
+11
+2% +$4.81K 0.08% 61
2026
Q1
$325K Sell
705
-7
-1% -$3.54K 0.1% 54
2025
Q4
$403K Buy
712
+7
+1% +$3.73K 0.13% 51
2025
Q3
$315K Sell
705
-31
-4% -$14.9K 0.1% 58
2025
Q2
$400K Sell
736
-31
-4% -$16.2K 0.13% 52
2025
Q1
$380K Buy
767
+107
+16% +$59.2K 0.13% 58
2024
Q4
$344K Buy
660
+40
+6% +$20.8K 0.12% 55
2024
Q3
$305K Buy
620
+5
+0.8% +$2.33K 0.12% 52
2024
Q2
$274K Buy
615
+88
+17% +$35K 0.12% 49
2024
Q1
$210K Buy
+527
New +$199K 0.12% 63

Other funds holding ISRG

Morling Financial Advisors's ISRG Position: Q2 2026 in Review

Morling Financial Advisors increased its Intuitive Surgical (ISRG) stake by 1.6% in Q2 2026, buying an estimated $4.81K and bringing the position to 716 shares worth $285K. The position accounts for 0.08% of the portfolio, ranked #61.

Morling Financial Advisors first reported a position in ISRG in Q1 2024 and has held it in 10 quarters since. The position peaked at $403K in Q4 2025. 2,236 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Morling Financial Advisors held 716 shares of Intuitive Surgical worth $285K as of Q2 2026.
  • Morling Financial Advisors bought 11 Intuitive Surgical shares in Q2 2026, an estimated $4.81K.
  • Intuitive Surgical made up 0.08% of Morling Financial Advisors's portfolio in Q2 2026, its #61 holding.
  • Morling Financial Advisors first reported a position in Intuitive Surgical in Q1 2024 and has held it in 10 quarters since.
  • Morling Financial Advisors's Intuitive Surgical position peaked at $403K in Q4 2025.
  • 2,236 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Morling Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.